Most read article(s)

Review
Potential Neurologic Manifestations of COVID-19
Anna S. Nordvig, Kathryn T. Fong, Joshua Z. Willey, et al.

June 30, 2020
Commentary
COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying Therapy
Andrew Wolf, Enrique Alvarez

April 14, 2021
Research
How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity
Ilya Kister, Tamar Bacon, Gary R. Cutter

May 28, 2021
Case
A Case Series of Guillain-Barré Syndrome After COVID-19 Infection in New York
Monica Chan, Steve C. Han, Sean Kelly, et al.

May 21, 2020
Research
Nusinersen Treatment in Adults With Spinal Muscular Atrophy
Tina Duong, Connie Wolford, Michael P. McDermott, et al.

January 25, 2021
Review
Multiple Sclerosis Phenotypes as a ContinuumThe Role of Neurologic Reserve
Timothy L. Vollmer, Kavita V. Nair, Ian M. Williams, et al.

January 29, 2021
Research
Medication Overuse and Headache BurdenResults From the CaMEO Study
Todd J. Schwedt, Dawn C. Buse, Charles E. Argoff, et al.

January 25, 2021
Case
COVID-19 Associated With Concomitant Varicella Zoster Viral Encephalitis
Pavan Patel, Anishee Undavia, Rabia Choudry, et al.

July 08, 2020
Research
Uptake and Attitudes About Immunizations in People With Multiple Sclerosis
Ruth Ann Marrie, Leanne Kosowan, Gary R. Cutter, et al.

April 22, 2021
Research
Quality and Safety Analysis of 2,999 Telemedicine Encounters During the COVID-19 Pandemic
Charuta N. Joshi, Michele L. Yang, Krista Eschbach, et al.

December 03, 2020

Pages